Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

This content is for healthcare professionals only.

Please confirm you are a healthcare professional.

Yes
No

The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

ERIC 2020

The European Research Initiative on CLL (ERIC) 2020 Virtual Meeting, New Frontiers in CLL Research, was held on 1-3 October 2020 and highlighted recent updates in the rational use of biomarkers, patient stratification, novel therapeutic targets, and appropriate patient management.

Leading experts in the field discussed the latest in CLL research, from basic to translational and clinical.

The full series of presentations can be viewed on-demand below.

With thanks to European Research Initiative on CLL and Open Audience for kind permission to VJHemOnc to share the proceedings online.

Day 1 Day 2 Day 3 CLL Channel

Day One

Day one of the meeting featured sessions on the genesis of CLL and disease trajectories.

Session I: The genesis of CLL
  • Exploring the roads to CLL; Freda Stevenson
  • MBL: Always a one-way ticket to CLL?; Lydia Scarfo
Session I
Session II: Disease trajectories: Outcomes, possible explanations and clinical implications
  • Spontaneous regression; Tatjana Stankovic
  • Clonal evolution: How is it reflected at the genome?; Catherine J. Wu
Session II

Day Two

Day two of the meeting featured sessions on resistance to apoptosis and proliferation.

Session I: The genesis of CLL
  • Exploring the roads to CLL; Freda Stevenson
  • MBL: Always a one-way ticket to CLL?; Lydia Scarfo
Session I
Session II: Disease trajectories: Outcomes, possible explanations and clinical implications
  • Spontaneous regression; Tatjana Stankovic
  • Clonal evolution: How is it reflected at the genome?; Catherine J. Wu
Session II

Day Three

Day three of the meeting featured a session on networking and collaboration, frontline treatment and management of relapsed/refractory disease.

Session I: The genesis of CLL
  • Exploring the roads to CLL; Freda Stevenson
  • MBL: Always a one-way ticket to CLL?; Lydia Scarfo
Session I
Session II: Disease trajectories: Outcomes, possible explanations and clinical implications
  • Spontaneous regression; Tatjana Stankovic
  • Clonal evolution: How is it reflected at the genome?; Catherine J. Wu
Session II

Check out our latest CLL content!

ERIC 2020 Presentations 0:00
ERIC 2020 Presentations

Our CLL Channel examines the latest updates across the CLL field.

With content featuring expert interviews from major international congresses this is one for your bookmarks!

To keep updated on all the latest in CLL and beyond, subscribe to our newsletter here.

 

The content of VJHemOnc is intended for healthcare professionals